Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. - Wikidata - wikimedia - TriplyDB

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

http://www.wikidata.org/entity/Q30514241

about

Knowledge Integration in Cancer: Current Landscape and Future Prospects STRengthening analytical thinking for observational studies: the STRATOS initiative Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review Biomarker validation and testing Endocannabinoids as biomarkers of human reproduction Predicting response to epigenetic therapy Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer Associations of P16INK4a promoter hypermethylation with squamous intra-epithelial lesion, cervical cancer and their clinicopathological features: a meta-analysis Biomarkers in reproductive medicine: the promise, and can it be fulfilled?Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example.Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation--protocol of the ICEM study.MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.Immune cells: plastic players along colorectal cancer progression The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.A simplified approach for the molecular classification of glioblastomas Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer.Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.

P2860

Q24289007-21A76CDA-4AA7-45CF-9005-3A20BB4D496C Q24289520-6C7EC248-9BB0-4FA3-9EB9-8E0117BF8560 Q24312148-3D10FCC8-A242-42D5-8CAA-C745469C8D48 Q26746258-54E30B1F-2952-40B2-B27D-EA74F4B3413A Q26782719-AF7B609B-4687-4C63-875F-CFF15791F7D6 Q26801108-F9B7C595-4EE7-432E-A051-A383437E9945 Q26849247-B859924B-FAB5-4A89-AB5B-773E0602865B Q26851333-3B9E3A22-0F46-4CAB-8CA7-A6E750C9965B Q26862139-36624AF0-8AFD-4CF4-93F5-38ECA6C57774 Q26863672-EF72601B-57B5-4120-9939-0B5F2531C95D Q27024033-6ECCC5EA-38F6-4BED-AD94-14CA39850725 Q27027751-427F0405-542B-4729-8040-8F15CB32D53C Q27308972-887029DE-AFEB-412B-A25B-F0F7BA118558 Q27853142-0B69A7D4-3078-4ACE-A170-16BD22816A01 Q27853326-9E4D11A7-FEEF-4067-8162-2EF0E30265FE Q28078542-04AFBE89-CEB6-41B5-A69C-6AE1EB58A427 Q28488305-650457D5-EE15-49C0-8A6C-5EFB1B43994D Q30234489-56C01E38-D708-4900-ABE3-D60C9E39F808 Q30238470-B4B1E5B6-073F-46C0-84F6-56E6205647EC Q30820418-5D970D4F-9C8A-44B7-9C2B-3A0186E5E354 Q31052319-75366A16-4375-4A6B-876B-CC9377FFA3CD Q31138958-55586022-628C-45B2-A646-48AB1D00578A Q33591545-FF1C2122-5DF8-4AFB-9460-56B41B2C2A33 Q33612332-D4E1A58F-AEC2-409C-8395-FA9E4C0D81D7 Q33659798-49984BEE-363B-4013-AE26-A3135BF744B2 Q33673813-D44D702B-55D3-438A-80BA-C2618B9A59F0 Q33843799-29F2A44F-827E-486B-AB4E-B65DA8F62DE0 Q33896545-05473E6B-A797-4F08-991F-D3644164C4BF Q33921056-58A27C79-6867-419B-8C32-4F1046ECC493 Q33958974-3A84D01A-763B-4DFE-A6BD-6D6580B29A8C Q33985586-0131D64D-6A65-4104-9A3A-656B1289F579 Q34134697-82275EE2-A0D4-43BA-9411-785CD201449D Q34408525-45F01CA5-F000-4D54-8F93-C79B8257957C Q34429149-9409825E-36E8-40FC-AB53-4C5B95350EB6 Q34429278-CA70EA1C-89A0-4E67-A09C-6FE063304B52 Q34478381-47BA261F-AD9D-4710-A61C-BDF4D25ACF1B Q34485296-E37F3618-AF60-4366-9138-6577DB11A995 Q34553646-D8FC204E-5F04-41BF-85FD-9266AF242FBC Q34566049-948E8A4A-1E93-4681-AE1C-CDC4BD789B82 Q34647811-5C54D3DA-2CAE-4FCD-A058-D39EF30AC190

P2860

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

http://www.wikidata.org/entity/Q30514241

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Reporting Recommendations for ...... : explanation and elaboration.

@ast

Reporting Recommendations for ...... : explanation and elaboration.

@en

type

label

Reporting Recommendations for ...... : explanation and elaboration.

@ast

Reporting Recommendations for ...... : explanation and elaboration.

@en

prefLabel

Reporting Recommendations for ...... : explanation and elaboration.

@ast

Reporting Recommendations for ...... : explanation and elaboration.

@en

P1433

Q30514241-CA87F3A6-CB64-4DAE-A67B-0ACD11727731

P1476

Q30514241-4E5FE823-7C0E-42FF-885C-DDF56085F6E4

P2093

Q30514241-201BFB85-2D72-42F0-A3DA-85E7734059BD

Q30514241-75BC8DFF-AAB4-4BF4-A775-5DE7188B6378

Q30514241-8878A9F7-08A4-4211-B57E-83A783581B49

P2860

Q30514241-00EB19F9-8D85-4B63-8EBA-8A4F8411415B

Q30514241-02B425BE-7C7C-4A2F-96A1-60CB55BCA4E7

Q30514241-050C0FD8-15F3-4303-A51A-D381288C111C

Q30514241-064240E1-2372-49DE-821E-862A839D0ACB

Q30514241-08BDF6DF-D131-4BE2-8A81-8A5045B64654

Q30514241-093890E8-0B27-4C92-ADA0-25D4FF6CE21C

Q30514241-09EA3A10-9F3E-4B70-B768-024B926CF573

Q30514241-0BC358E9-673F-49A6-A5ED-22B16B88D2DA

Q30514241-0D1142F2-5B18-4BF6-B9DB-CE8E19CB0A12

Q30514241-0D9EA370-0BAE-46AC-B36B-1B70C2F4EA01

P304

Q30514241-51E54EFE-764B-49AF-B537-62BE008CBE85

P31

Q30514241-7B80CD5B-F426-4190-8403-B64EF333DC81

P356

Q30514241-BA8DCFCD-070E-4255-8D14-ABB5B337ECCA

P407

Q30514241-7526465B-B0AE-42C9-B25F-9DF0E849E83B

P433

Q30514241-7239B854-D040-40D2-A940-1D17022DB60B

P478

Q30514241-FBC16141-7491-4D6E-9E6F-4BF13304C1E6

P50

Q30514241-79742376-B39A-4373-87A9-D79951929F37

P577

Q30514241-B8FA53B8-0EAF-468C-969B-B71CA3F33868

P5875

Q30514241-502EB4F6-4F52-4987-84CF-8AD4C328FA6A

P698

Q30514241-AB766A6C-1D62-4735-B335-A4244E8F8520

P932

Q30514241-7C1D2A87-0755-4BBE-986F-000D941AC606

P356

JOURNAL.PMED.1001216

P1433

P1476

Reporting Recommendations for ...... : explanation and elaboration.

@en

P2093

Lisa M McShane

http://www.w3.org/2001/XMLSchema#string

Sheila E Taube

http://www.w3.org/2001/XMLSchema#string

Willi Sauerbrei

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Why Most Discovered True Associations Are Inflated

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

Survival analysis part II: multivariate data analysis--an introduction to concepts and methods

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

P304

e1001216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1001216

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Douglas G. Altman

P577

2012-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225276404

http://www.w3.org/2001/XMLSchema#string

P698

22675273

http://www.w3.org/2001/XMLSchema#string

P932

3362085

http://www.w3.org/2001/XMLSchema#string